Skip to main content

Follow us

Home

Search

the Gateway to Research in Oklahoma

  • Researchers
  • Providers
  • Patients
  • About GRO

Gateway to Research in Oklahoma


Oklahoma Shared Clinical and Translational Resources U54 GM104938

Researchers

imgResearchers

The GRO: Researcher Portal provides resources, information, and training to help individuals or communities involved in performing clinical and translational research in Oklahoma.

Providers

imgProviders

The GRO: Provider Portal assists medical providers to identify clinical research opportunities in Oklahoma, tools for patient education, and evidence-based resources to improve patient care.

Patients

imgPatients

The GRO: Patient Portal can help patients and families to learn more about clinical and translational research and to connect with opportunities to participate in research opportunities in your communities.

Oklahoma Research Highlights

Sex Differences in the Association Between Childhood Cyberbullying Victimization and College Sexual Assault: Moderating Roles of Parental Monitoring and Relationship with Deviant Peers

3 months 2 weeks ago
This study explores sex differences in the relationship between childhood cyberbullying victimization (CCBV) and young adult sexual assault experiences and the potential moderating roles of childhood parent monitoring and deviant peer association on the relationship. A total of 356 college students aged 19-25 in the US participated in the online survey. The results indicated that CCBV was associated with an increased risk of college sexual assault victimization for both males and females. A...
Jungup Lee

Wettability effects on interfacial rheology and stability of particle-laden oil-water interfaces

3 months 2 weeks ago
HYPOTHESIS: The wettability of colloidal particles alters the balance between capillary attraction and electrostatic repulsion at the oil-water interface, leading to distinct microstructures and impacting how particle-laden interfaces respond to applied stresses.
Eduarda B Oliveira

Atorvastatin suppresses HIV/antiretroviral drug-induced cardiac fibrosis and dysfunction in mice by blocking platelet TGFβ1 signaling

3 months 2 weeks ago
Cardiovascular disease (CVD), both atherosclerosis-related and heart failure with preserved ejection fraction (HFpEF) linked to cardiac fibrosis, contributes to morbidity and mortality in people with HIV (PWH) receiving antiretroviral therapy (ART). In the REPRIEVE trial, pitavastatin reduces atherosclerotic CVD risk to a magnitude inconsistent with pitavastatin's impact solely on LDL-cholesterol and inflammation. We hypothesized that HFpEF in PWH is related to HIV-induced fibrosis mediated by...
Kumar Subramani

A delayed pharmacological treatment strategy attenuates noise-induced tinnitus in rats

3 months 2 weeks ago
It is widely accepted that tinnitus arises from maladaptive neuroplasticity in the central auditory system, which compensates for reduced peripheral input; notably, the loss of inner hair cell (IHC) synapses is considered a key underlying factor. IHC synapses can immediately and permanently degenerate after noise exposure, independent of hair cell loss, whereas the cell bodies and central projections of cochlear neurons can survive for months to years, providing an extended therapeutic window...
Jianzhong Lu

Correction: Secondary metabolites from <em>Lobaria pulmonaria</em> (L.) Hoffm. target key metabolic enzymes: a novel strategy against multidrug-resistant tuberculosis

3 months 2 weeks ago
[This corrects the article DOI: 10.1039/D5RA05774D.].
Ha Thi Nguyen

Pagination

  • Previous page ‹ Previous
  • Page 12
  • Next page Next ›
Subscribe to

octsi logo

1000 N. Lincoln Blvd, Suite 2100, Oklahoma City, OK 73104
Copyright © 2021 The Board of Regents of the University of Oklahoma, All Rights Reserved.

About GRO

News
Publications
FAQ

Terms of Use

Privacy Policy
Accessibility

Contact

info email
info phone
Copyright © 2026. All rights reserved. Designed By Zymphonies